[grow_thumb image=”https://telecareaware.com/wp-content/uploads/2017/04/babylon_lifestyle2.jpg” thumb_width=”150″ /]Babylon Health, which has developed an AI-assisted chatbot to triage a potential patient in minutes, has raised a serious Series B of £50 million (US$60 million). Funders were Kinnevik AB, which had led the Series A, NNC Holdings, and Vostok New Ventures (Crunchbase). According to the FT (through TechCrunch), Babylon’s value is now north of $200 million. Revenues were not disclosed.
The current app uses texts to determine the level of further care, recommends a course of action, then connects the user if needed to a virtual doctor visit, or if acute to go to Accident & Emergency (US=emergency room or department). It also follows up with the user on their test results and health info. The funding will be used to enhance their current AI to extend to diagnosis. They are accumulating daily data on thousands of patients, machine learning which further refines the AI. Founder Dr. Ali Parsa, founder and CEO of Babylon, said in a statement. “Babylon scientists predict that we will shortly be able to diagnose and foresee personal health issues better than doctors, but this is about machines and medics cooperating, not competing.” Like other forms of telemedicine and triage (Zipnosis in health systems), it is designed to put healthcare access and affordability, as they claim, “into the hands of every person on earth”. The NHS pilot in north London [TTA 18 Jan] via the 111 hotline is testing Babylon as a ‘reliever’ though it directs only to a doctor appointment, not a video consult. BBC News, Mobihealthnews